2022
DOI: 10.3390/jcm11195826
|View full text |Cite
|
Sign up to set email alerts
|

Review and Updates on the Diagnosis of Tuberculosis

Abstract: Diagnosis of tuberculosis, and especially the diagnosis of extrapulmonary tuberculosis, still faces challenges in clinical practice. There are several reasons for this. Methods based on the detection of Mycobacterium tuberculosis (Mtb) are insufficiently sensitive, methods based on the detection of Mtb-specific immune responses cannot always differentiate active disease from latent infection, and some of the serological markers of infection with Mtb are insufficiently specific to differentiate tuberculosis fro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 109 publications
(120 reference statements)
0
14
0
Order By: Relevance
“…Worldwide, the most commonly used molecular test for the diagnosis of TB is Xpert MTB/RIF, approved by the World Health Organization in 2013. When performed directly in specimens, it can detect the DNA of the MT complex in biopsies and the rifampicin (RIF) resistance conferred by the rpoB gene mutation detected by nested real-time PCR within 2 h. This test is generally available in less than 24 h[ 3 , 9 ]. Thus, over the last decade, these molecular tests have played an essential role in controlling TB[ 3 ].…”
Section: Genxpert Mt or Xpert Mtb/rif Assaymentioning
confidence: 99%
See 1 more Smart Citation
“…Worldwide, the most commonly used molecular test for the diagnosis of TB is Xpert MTB/RIF, approved by the World Health Organization in 2013. When performed directly in specimens, it can detect the DNA of the MT complex in biopsies and the rifampicin (RIF) resistance conferred by the rpoB gene mutation detected by nested real-time PCR within 2 h. This test is generally available in less than 24 h[ 3 , 9 ]. Thus, over the last decade, these molecular tests have played an essential role in controlling TB[ 3 ].…”
Section: Genxpert Mt or Xpert Mtb/rif Assaymentioning
confidence: 99%
“…The most common site of TB is the lungs; however, in approximately 12.5% of cases, it can affect other sites (extrapulmonary TB), with abdominal localization in 11%-16%[ 2 ]. The diagnosis of extrapulmonary TB can be very challenging because the usual method based on the detection of MT is insufficiently sensitive, and other tools based on immune responses cannot always differentiate a latent infection from an active disease[ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Early identification of ATB patients and implementation of preventive measures to halt LTBI progression into ATB represent critical measures for controlling and eliminating TB [ 5 ]. However, the absence of specific biomarkers to identify LTBI subpopulations at risk of ATB progression remains a major challenge in TB prevention [ 6 ]. Thus, there is an urgent need to develop advanced molecular tools for TB risk stratification.…”
Section: Introductionmentioning
confidence: 99%
“…Tuberculosis (TB) is a pressing global public health issue, contributing significantly to both morbidity and mortality. Prior to the emergence of the COVID-19 pandemic, TB held a more prominent position than HIV/AIDS in terms of its impact on mortality [1], resulting in about 1.3 million annual fatalities and 10 million new cases in 2018, with over half occurring in developing nations [2]. While the prevalence and mortality of pulmonary TB has decreased globally due to anti-tuberculosis drugs and socio-economic improvements, the opposite trend has occurred with extra-pulmonary TB [3].…”
Section: Introductionmentioning
confidence: 99%